Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CUB and sushi domain-containing protein 3 (CSMD3) is a giant transmembrane protein encoded by the CSMD3 gene, located on chromosome 8q23.3-q24.1[1][4]. The gene consists of 73 exons and is primarily expressed in the adult and fetal brain[1][2]. CSMD3 belongs to the CSMD family, which shares homology with CSMD1 and CSMD2, and contains structural CUB and Sushi domains associated with protein-protein interactions and complement control[1][2][5]. CSMD3 is involved in dendrite development and has been implicated as a candidate gene in benign adult familial myoclonic epilepsy[1][2]. It is also associated with several cancers, including ovarian and uterine corpus endometrial carcinoma, suggesting potential tumor suppressor activity[2][1]. There are currently no drugs known to target CSMD3 directly, and no specific biomarkers or safety concerns have been identified in the literature[2][5].
Not applicable (no drugs reported to directly target CSMD3)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CUB and sushi domain-containing protein 3 (CSMD3).